Trouble with images? View as a Web page.

Polsinelli - Environmental and Natural Resources
         
 

December 2013

 

Compounding Quality Act: Critical Implementation Begins Now for Stakeholders

 
 
             
 

Life Sciences Professionals:

 

Kevin R. Sweeney

Practice Area Chair

 

Ari M. Bai
Mary Beth Blake
Yu Cai
Elton F. Dean III
Kathryn J. Doty
Robert O. Enyard Jr.
Anita R. Estell
Geoffrey D. Fasel
Ron Galant
Melissa Gilmore
Kimberly A. Honeycutt
Andrew T. Hoyne
J. Morgan Kirley
Gregory M. Kratofil
Jane K. McCahill
Cortney E. Mendenhall
Tara A. Nealey
Jay E. Pietig
Andrea M. Porterfield
Rebecca C. Riley-Vargas
Thomas J. Schenkelberg
Kelley A. Schnieders
Teddy C. Scott
Christopher P. Simpson
Timothy D. Steffens
James M. Stipek
Steven K. Stranne
Kevin R. Sweeney
Tracey S. Truitt
Brian G. Wallace
Michael A. Williamson
Patrick C. Woolley

 

To learn more about our Life Sciences practice, or to contact one of our Life Sciences attorneys, click here.

 

View Polsinelli documents on JD Supra  
LinkedIn Twitter Facebook Inside Law Podcast Connect with us on LinkedIn. Connection with us on Twitter. Connect with us on Facebook.

 

   

On Wednesday, December 4, FDA will publish six key documents in the implementation of the Compounding Quality Act, signed into law by President Obama on Monday, December 2. In addition, FDA has withdrawn its current guidance entitled "Enforcement Policy During Implementation of Section 503A of the Federal Food, Drug, and Cosmetic Act," as well as CPG Section 460.200 of the Compliance Program Guidance Manual entitled "Pharmacy Compounding," which had until today represented FDA's stance on, and enforcement of, human drug compounding. Stakeholders are urged to review the documents, which will directly affect their businesses. FDA strongly requests all stakeholders to provide FDA with lists of what bulk APIs should be continued to be permitted to be used in compounding, what compounding practices will still be permitted under state pharmacy law, and other issues critical to the continuation of their businesses.

Advance copies of these proposed rules and notices are available here:

For More Information

For more information about the contents of this eAlert, please contact the author:

 
             
             

             
 

Chattanooga  Chicago  Dallas  Denver  Edwardsville  Jefferson City  Kansas City  Los Angeles  New York  Overland Park
Phoenix  St. Joseph  St. Louis  Springfield  Topeka  Washington, D.C.  Wilmington  
www.polsinelli.com

 
             
 
 

ABOUT POLSINELLI

real challenges. real answers.SM  
Serving corporations, institutions, entrepreneurs, and individuals, our attorneys build enduring relationships by providing legal counsel informed by business insight to help clients achieve their objectives. This commitment to understanding our clients' businesses has helped us become the fastest growing law firm in the U.S. for the past five years, according to the leading legal business and law firm publication,
The American Lawyer. Our more than 680 attorneys in 17 cities work with clients nationally to address the challenges of their roles in health care, financial services, real estate, life sciences and technology, energy and business litigation. The firm can be found online at www.polsinelli.com. Polsinelli PC. In California, Polsinelli LLP.

 
 
             
 

To update your email preferences, please contact Kim Auther at KAuther@polsinelli.com. To opt out of these communications, click the unsubscribe link below.

Polsinelli provides this material for informational purposes only. The material provided herein is general and is not intended to be legal advice. The choice of a lawyer is an important decision and should not be based solely upon advertisements.

Copyright © 2013 Polsinelli PC.

 
             
Connect with us on LinkedIn. Connection with us on Twitter. Connect with us on Facebook.